Ciprofloxacin monotherapy and bacterial keratitis.
Katz
H R
HR
D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000188:drug therapy / Q000382:microbiology*; D003352:Corynebacterium / Q000187:drug effects* / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
D000890:Anti-Infective Agents; D002939:Ciprofloxacin